Aducanumab: A Deep Dive into BIIB037 and its Impact The drug, originally known as BIIB037, constitutes a notable effort to address early-stage Alzheimer's disease. Created by Biogen, this molecule works by clearing https://www.targetmol.com/compound/aducanumab